Catalys Pacific, LLC — Q2 2024 13F-HR

← Catalys Pacific, LLC

Q2 2024 · 13F-HR

Catalys Pacific, LLCholdings as filed

Filed 2024-08-13 · accession 0001104659-24-088833

$132.5M

Reported value

Positions

2024-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
603170101	MLYS	Mineralys Therapeutics, Inc.	$107.6M	81.2%	9,194,579	Common	SOLE
43157M102	—	HilleVax, Inc.	$17.5M	13.2%	1,208,974	Common	SOLE
71722W107	PHAT	Phathom Pharmaceuticals, Inc.	$7.4M	5.61%	721,962	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.